Search results
Results from the WOW.Com Content Network
It comprises tests of attention, memory (7-item name and address), letter fluency, clock drawing, and memory recall, and takes under five minutes to administer. The M-ACE is scored out of 30, with a higher score indicating better cognitive function, and has two recommended cut-off scores (25 and 21). The higher cut-off score has both high ...
Other studies have tested the MoCA on patients with Alzheimer's disease. [6] [7] [8] People with hearing loss, which commonly occurs alongside dementia, score worse in the MoCA test, which could lead to a false diagnosis of dementia. Researchers have developed an adapted version of the MoCA test, which is accurate and reliable and avoids the ...
The MMSE may help differentiate different types of dementias. People with Alzheimer's disease may score significantly lower on orientation to time and place as well as recall, compared to those who have dementia with Lewy bodies, vascular dementia, or Parkinson's disease dementia. [25] [26] [27]
A main theory behind the cause of Alzheimer’s disease is the build-up of the protein amyloid-beta in the brain. Researchers from the University of Cincinnati provide evidence suggesting it’s ...
WRBTV: [9] The Vienna Risk-taking Test Traffic (WRBTV) is an objective personality test that measures readiness to take risks when driving. It is based on the risk homeostasis theory of the Canadian psychologist G. J. S. Wilde. FGT: [10] The Figural Memory Test (FGT) is a language-free test of figural learning ability and figural episodic ...
A driving test generally consists of one or two parts: the practical test (sometimes called a road test in the United States), used to assess a person's driving ability under normal operating conditions, [1] and a theory test (written, oral or computerized) to confirm a person's knowledge of driving and relevant rules and laws.
New research finds a blood test accurately diagnoses Alzheimer’s disease in patients. The blood test was 90% accurate in the study. This blood test is currently available in the U.S.
A new study distinguishes between two distinct phases of Alzheimer's disease: an early, 'stealth' one without symptoms, and a second phase that aggressively damages the brain.